Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current status of clinical proteogenomics in lung cancer

12 Aug 2019

Abstract excerpt

Introduction: Lung cancer is the leading cause of cancer death worldwide. Proteogenomics, a way to integrate genomics, transcriptomics, and proteomics, have emerged as a way to understand molecular causes in cancer tumorigenesis. This understanding will help identify therapeutic targets that are urgently needed to improve individual patient outcomes.Areas covered: To explore underlying molecular mechanisms of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Genomics and Phylogenetic Studies
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31402712
DOI: 10.1080/14789450.2019.1654861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current status of clinical proteogenomics in lung cancerPMID 31402712Read ↗

Developments for Personalized Medicine of Lung Cancer Subtypes: Mass Spectrometry-Based Clinical Proteogenomic Analysis of Oncogenic Mutations.Semantic proximity Read ↗

Molecular Pathology of Lung Cancer.Semantic proximity Read ↗

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applicationsSemantic proximity Read ↗

Comprehensive Network Analysis of Different Subtypes of Molecular Disorders in Lung CancerSemantic proximity Read ↗

Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.Semantic proximity Read ↗

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read ↗

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer managementSemantic proximity Read ↗

Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures.Semantic proximity Read ↗

Integrative Proteomic Characterization of Human Lung Adenocarcinoma.Semantic proximity Read ↗

In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate BiomarkersSemantic proximity Read ↗

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.Semantic proximity Read ↗

Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879VSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.